GREY:IPHAF - Post by User
Post by
labumbaon Oct 26, 2009 12:49pm
445 Views
Post# 16423957
go for RA indication
go for RA indication " The results from these clinical trials suggest that LX211 may have the potential to significantly change the face of uveitis therapy, based on its ability to modify the course of the disease. This is analogous to the advent of disease-modifying anti-rheumatic drugs (DMARD’s) and their impact on the course of rheumatoid arthritis.”
----------------------------------------------------------------------------------------
Professional 11........you are really ahead of us.....You re from the States...right ?